Shares of Hims & Hers Health Inc. (HIMS) took a sharp 5.03% dive in pre-market trading on Wednesday, following a remarkable 18.1% surge the previous day. This volatility comes in the wake of the company's mixed first-quarter earnings report and lower-than-expected future guidance.
On Tuesday, Hims & Hers Health, a telehealth company specializing in personal care and wellness products, reported first-quarter earnings that surpassed Wall Street estimates. However, the company also introduced long-term sales guidance that fell short of market expectations. For the second quarter, Hims & Hers projected revenue between $530 million and $550 million, significantly below analysts' expectations of $564.6 million.
The pre-market plunge on Wednesday appears to be a correction following Tuesday's enthusiastic market response. Investors seem to be reassessing the company's outlook in light of the softer revenue guidance, despite the better-than-expected quarterly results. This rapid shift in sentiment underscores the market's sensitivity to future projections, especially for growth-oriented companies in the competitive telehealth sector.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.